Medtech POV Blog

Medtech Moves Us: Looking Ahead to The MedTech Conference 2026

Momentum is building for The MedTech Conference, October 18–21, 2026, in Boston, and I hope you’ll join us. With AdvaMed member participation at an all-time high, expanding international engagement, and our largest Medtech Campus ever, this year’s conference brings together the people and perspectives shaping what comes next for our industry. 

Our shared mission, putting patients first, remains at the center of these conversations. As companies navigate advances in AI, a fast-moving regulatory environment, and new investment and market access opportunities, connecting with the right people and insights matters more than ever. 

Our theme, “Medtech Moves Us,” reflects both the impact of our industry and the value of coming together to move it forward. Here’s what awaits you in Boston: 

  • Record member participation and new connections. Join AdvaMed members, CEOs, and leaders across business development, R&D, regulatory, clinical affairs, and strategy. Nearly half of registered attendees are new, creating fresh opportunities to build relationships across the medtech community. 
  • Timely education curated by industry leaders. Our education and program team has spent months developing conversations around the decisions facing your business: how AI and digital health are changing care, what it takes to commercialize innovation, and how companies can navigate global markets and improve patient access. Hear directly from medtech executives, policy experts, CMS and senior FDA CDRH leaders. 
  • Expanded investor programming and business development opportunities. Connect with investors and strategic partners, explore emerging innovations, and hear leading medtech companies outline their investment and partnering priorities through corporate reverse pitches. Make the most of your time in Boston by arranging 1:1 partnering meetings before you arrive. 
  • Highlights of the Keynote Stage. Hear from Mick Farrell of Resmed, Mike Mahoney of Boston Scientific, Ashley McEvoy of Insulet, and Robbie Marcus of J.P. Morgan in a discussion moderated by John Babitt of EY, with additional perspectives from Johnson & Johnson MedTech and Operation Smile. Get a firsthand perspective from Dr. Michelle Tarver as the Director, CDRH and other senior FDA CDRH leaders on the regulatory issues shaping the future.  
  • Our largest Medtech Campus ever. With 185+ presenting companies and more than 500 speakers across the Campus and education sessions, you’ll find new ideas, practical insights, and opportunities to do business. Explore live demonstrations in the Tech in Motion Hub, emerging company pitches, and conversations spanning the full medtech ecosystem. 
  • A growing global community and the next generation of medtech. Strong participation from Europe, the UK, Central America, and our new Nordic-Baltic delegation will bring valuable international perspectives. Dedicated opportunities for students, veterans, and early-career professionals will help connect tomorrow’s leaders with the industry they will help shape. 

The value of Boston is what you can take back to your organization: a new relationship, a clearer strategy, or an opportunity that moves your business forward. 

Explore the 2026 program and register today.  

Scott Whitaker

Scott Whitaker, President and CEO, AdvaMed

  

Hear Patient Stories

The Story of Medtech empowers patients to share their experiences with medical technology in an effort to educate, inspire, and create community.